Δημοσιεύσεις

Δρ. Ευαγγελία Χαρμανδάρη

MD, MSc, PhD, MRCP(UK), CCST(UK)
Καθηγήτρια Παιδιατρικής – Παιδιατρικής και Εφηβικής Ενδοκρινολογίας
Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
Α’ Παιδιατρική Κλινική, Νοσοκομείο Παίδων “Η Αγία Σοφία”

Δημοσιεύσεις σε Διεθνή Περιοδικά του SCI​

2019

108. Giannios G, Gennitsaridi S, Kolaitis G, Nicolaides NC, Farakla I, Karampatsou S, Papageorgiou I, Kassari P, Papadopoulou P, Charmandari E. The effect of vitamin D supplementation on cardiometabolic risk factors and mental health symptoms in obese children. Journal of Molecular Biochemistry (in press).

107. Genitsaridi SM, Karampatsou S, Papageorgiou I, AMantzou A, Papathanasiou C, Kassari P, Paltoglou G, Kourkouti C, Charmandari E. Hair cortisol concentrations in overweight and obese children and adolescentsHormone Research in Paediatrics 2019;92(4):229-236.

106. Stefa A, Lamprokostopoulou A, Briana D, Kontogeorgou A, Papageorgiou I, Malamitsi-Puchner A, Tsitsilonis O, Gagos S, Charmandari EThe effect of intrauterine growth on leukocyte telomere length at birthJournal of Maternal-Fetal & Neonatal Medicine 2018; 6: 1-6.

105. Lamprokostopoulou A, Moschonis G, Manios Y, Critselis E, Nicolaides NC, Stefa A, Koniari E, Gagos S, Charmandari E. Childhood obesity and leukocyte telomere lengthEuropean Journal of Clinical Investigation 2019; e13178.

104. Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R. Research update for articles published in EJCI in 2017European Journal of Clinical Investigation 2019; 49(10): e13163.

103. Nicolaides NC, Polyzos A, Koniari E, Lamprokostopoulou A, Papageorgiou I, Golfinopoulou E, Papathanasiou C, Sertedaki A, Thanos D, Chrousos GP, Charmandari ETranscriptomics in tissue glucocorticoid sensitivityEuropean Journal of Clinical Investigation 2019; e13129.

102. Gray LJ, Brady EM, Albaina O, Edwardson CL, Harrington D, Khunti K, Miksza J, Raposo JF, Smith E, Vazeou A, Vergara I, Weihrauch-Blüher S, Davies MJ; PRE-STARt Collaborative (Charmandari E). Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional studyBMC Endocrine Disorders 2019; 19(1): 79.

101. Moschonis G, Michalopoulou M, Tsoutsoulopoulou K, Vlachopapadopoulou E, Michalacos S, Charmandari E, Chrousos GP, Manios Y. Assessment of the effectiveness of a computerised decision-support tool for health professionals for the prevention and treatment of childhood obesity. Results from a randomised controlled trialNutrients. 2019; 11(3). pii: E706.

100. Farakla I, Koui E, Arditi J, Papageorgiou I, Bartzeliotou A, Papadopoulos GE, Mantzou A, Papathanasiou C, Dracopoulou M, Papastamataki M, Moutsatsou P, Papassotiriou I, Chrousos GP, Charmandari EEffect of honey on glucose and insulin concentrations in obese girlsEuropean Journal of Clinical Investigation 2019; 49(2): e13042.

99. Polytarchou A, Katsouli G, Tsaoussoglou M, Charmandari E, Kanaka-Gantenbein C, Chrousos G, Kaditis AG. Obstructive events in children with Prader-Willi syndrome occur predominantly during rapid eye movement sleepSleep Medicine 2018; 54: 43-47.

98. Nicolaides NC, Charmandari E. Glucocorticoid resistance. Exp Suppl. 2019; 111:85-102.

97. Krishna KB, Fuqua JS, Popovic J, Rogol AD, Houk CP, Charmandari E, Lee PA. Use of Gonadotropin-releasing hormone analogs (GnRHa) in children: Update by an International ConsortiumHormone Research in Paediatrics 2019; 91(6): 357-372.

2018

96. Katsarou MS, Karathanasopoulou A, Andrianopoulou A, Desiniotis V, Tzinis E, Dimitrakis E, Lagiou M, Charmandari E, Aschner M, Tsatsakis AM, Chrousos GP, Drakoulis N. Beta 1, Beta 2 and Beta 3 adrenergic receptor gene polymorphisms in a Southeastern European populationFrontiers in Genetics 2018; 9:560.

95. Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK, Bouzas-Mosquera A. Research update for articles published in EJCI in 2016European Journal of Clinical Investigation 2018; 48(10): e13016.

94. Emmanouil CC, Pervanidou P, Charmandari E, Darviri C, Chrousos GP. The effectiveness of a health promotion and stress-management intervention program in a sample of obese children and adolescentsHormones (Athens). 2018; 17(3): 405-413.

93. Kassari P, Papaioannou P, Billiris A, Karanikas H, Eleftheriou S, Thireos E, Manios Y, Chrousos GP, Charmandari EElectronic registry for the management of childhood obesity in GreeceEuropean Journal of Clinical Investigation 2018; 48(3).

2017

92. Vardas K, Ilia S, Sertedaki A, Charmandari E, Briassouli E, Goukos D, Apostolou K, Psarra K, Botoula E, Tsagarakis S, Magira E, Routsi C, Stratakis CA, Nanas S, Briassoulis G. Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortalityIntensive Care Medicine Experimental 2017; 5(1): 10.

91. Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, Hernández-Mijares A, Kalantaridou SN, Krause R, Latini R, Makrigiannakis A, Marín F, Masson S, Montecucco F, Ndrepepa G, Nicolaides NC, Novelli D, Orasan OH, Qorbani M, Ratzinger F, Roessler A, Sabico S, Sciatti E, Stefanaki C, Stoner L, Tabatabaei-Malazy O, Tatar E, Toz H, Uslu A, Victor VM, Vizzardi E. Research update for articles published in EJCI in 2015European Journal of Clinical Investigation 2017; 47(10): 775-788.

90. Bacopoulou F, Kolias E, Efthymiou V, Antonopoulos CN, Charmandari EVitamin D predictors in polycystic ovary syndrome: A meta-analysisEuropean Journal of Clinical Investigation 2017; 47(10): 746-755.

89. Nicolaides NC, Charmandari E, Kino T, Chrousos GP. Stress-Related and circadian secretion and target tissue actions of glucocorticoids: Impact on health.Frontiers in Endocrinology (Lausanne). 2017; 8:70.

88. Nicolaides NC, Charmandari Eovel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromesHormones (Athens). 2017; 16(2): 124-138.

87. Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E, Chrousos GP. Paediatric stress: from neuroendocrinology to contemporary disordersEuropean Journal of Clinical Investigation 2017; 47(3): 262-269.

86. Kyritsi EM, Koltsida G, Farakla I, Papanikolaou A, Critselis E, Mantzou E, Zoumakis E, Kolaitis G, Chrousos GP, Charmandari EPsychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHormones (Athens). 2017; 16(1): 42-53.

85. Papageorgiou L, Vlachakis C, Dragoumani K, Raftopoulou S, Brouzas D, Nicolaides NC, Chrousos GP, Charmandari E, Megalooikonomou V, Vlachakis D. HCV genetics and genotypes dictate future antiviral strategiesJournal of Molecular Biochemistry 2017; 6: 33-40.

84. Nicolaides NC, Kino T, Roberts ML, Katsantoni E, Sertedaki A, Moutsatsou P, Psarra AG, Chrousos GP, Charmandari EThe Role of S-Palmitoylation of the human glucocorticoid receptor (hGR) in mediating the nongenomic glucocorticoid actionsJournal of Molecular Biochemistry 2017; 6(1): 3-12.

2016

83. Sertedaki A, Markou A, Vlachakis D, Kossida S, Campanac E, Hoffman DA, Sierra ML, Xekouki P, Stratakis CA, Kaltsas G, Piaditis GP, Chrousos GP, Charmandari E. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretionClinical Endocrinology (Oxford) 2016; 85(6): 845-851.

82. Kassi E, Semaniakou A, Sertedaki A, Evangelopoulos ME, Kazazoglou T, Kominakis A, Sfagos C, Charmandari E, Chrousos GP, Moutsatsou P. Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patientsJournal of Neurological Science 2016; 363: 165-169.

81. Hurt DE, Suzuki S, Mayama T, Charmandari E, Kino T. Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-binding DomainsMolecular Endocrinology 2016; 2016; 30(2): 173-188.

80. Nicolaides NC, Skyrla E, Vlachakis D, Psarra AG, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E. Functional Characterization of the hGRαT556I causing Chrousos syndromeEuropean Journal of Clinical Investigation 2016; 46(1): 42-49.

79. Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, Mazur T, Meyer-Bahlburg HF, Mouriquand P, Quigley CA, Sandberg DE, Vilain E, Witchel S; Global DSD Update Consortium (Charmandari E)Global Disorders of Sex Development Update since 2006: Perceptions, Approach and CareHorm Res Paediatr. 2016; 85(3): 158-80.

78. Nicolaides NC, Lamprokostopoulou A, Sertedaki A, Charmandari ERecent advances in the Molecular Mechanisms Causing Primary Generalized Glucocorticoid ResistanceHormones (Athens) 2016; 15(1): 23-34.

77. Stavrou S, Nicolaides NC, Papageorgiou I, Papadopoulou P, Terzioglou E, Darviri C, Chrousos GP, Charmandari E. The effectiveness of a stress-management intervention program in the management of overweight and obesity in childhood and adolescenceJournal of Molecular Biochemistry 2016; 5(2): 63-70.

76. Charmandari E, Zhang RG, Silveira LG, Fan QR, Chrousos GP, Sertedaki A, Latronico AC, Segaloff DL. Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone StimulationMolecular Endocrinology 2016; 30(1): 62-76.

2015

75. Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, Christophoridis A, Katzos G, Dracopoulou M, Sertedaki A, Chrousos GP, Charmandari E. Transient Generalized Glucocorticoid HypersensitivityEuropean Journal of Clinical Investigation 2015; 45(12): 1306-1315.

74. Nicolaides NC, Geer EB, Vlachakis D, Roberts ML, Psarra AG, Moutsatsou P, Sertedaki A, Kossida S, Charmandari EA novel mutation of the hGR gene causing Chrousos syndromeEuropean Journal of Clinical Investigation 2015; 45(8): 782-791.

73. Markou A, Sertedaki A, Kaltsas G, Androulakis I, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP. Stress-induced aldosterone hypersecretion in a substantial subset of patients with essential pypertensionJournal of Clinical Endocrinology & Metabolism 2015; 100(8): 2857-2864.

72. Nicolaides NC, Charmandari EChrousos syndrome from molecular pathogenesis to therapeutic managementEuropean Journal of Clinical Investigation 2015; 45(5): 504-514.

71. Hindmarsh PC, Charmandari EVariation in absorption and half-life of hydrocortisone influence plasma cortisol concentrationsClinical Endocrinology (Oxford) 2015; 82(4): 557-561.

70. Nicolaides N, Kyratzi E, Lamprokostopoulou A, Chrousos G, Charmandari EStress, the stress system and the role of glucocorticoidsNeuroimmunomodulation 2015; 22(1-2): 6-19.

2014

69. Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptorBMC Endocrine Disorders 2014; 14: 71.

68. Charmandari E, Nicolaides N, Chrousos GP. Adrenal InsufficiencyLancet 2014; 383(9935): 2152-67.

67. Nicolaides N, Charmandari E, Chrousos GP, Kino T. Circadian Endocrine Rhythms: HPA Axis and its actionsAnnals of the New York Academy of Sciences 2014; 1318: 71-80.

66. Moschonis G, Kalliora AC, Costarelli V, Papandreou C, Koutoukidis D, Lionis C, Chrousos GP, Manios Y; Healthy Growth Study Group (Charmandari E). Identification of lifestyle patterns associated with obesity and fat mass in children: the Healthy Growth StudyPublic Health Nutrition 2014; 17(3): 614-624.

65. Manios Y, Moschonis G, Papandreou C, Siatitsa PE, Iatridi V, Lidoriki I, Lionis C, Chrousos GP; Healthy Growth Study group (Charmandari E)Female sex, small size at birth and low family income increase the likelihood of insulin resistance in late childhood: the Healthy Growth StudyPediatric Diabetes 2014; 15(1): 41-50.

64. Nicolaides NC, Roberts ML, Kino T, Braatvedt G, Hurt DE, Katsantoni E, Sertedaki A, Chrousos GP, Charmandari E. A novel point mutation of the human glucocorticoid receptor gene causes Primary Generalized Glucocorticoid Resistance through impaired interaction with the LXXLL motif of the p160 coactivators: Dissociation of the transactivating and transreppressive activitiesJournal of Clinical Endocrinology & Metabolism 2014; 99(5): E902-7.

63. Androutsos O, Moschonis G, Koumpitski A, Mantzou A, Roma-Giannikou E, Chrousos GP, Manios Y, Kanaka-Gantenbein C; “Healthy Growth Study” Group (Charmandari E)The correlation of right 2D:4D finger length ratio to the low-grade inflammation marker IL-6 in children. The Healthy Growth Study. Early Human Development 2014; 90(1): 61-65.

2013

62. Manios Y, Birbilis M, Moschonis G, Birbilis G, Mougios V, Lionis C, Chrousos GP; ‘Healthy Growth Study’ group (Charmandari E)Childhood Obesity Risk Evaluation based on perinatal factors and family sociodemographic characteristics: CORE indexEuropean Journal of Pediatrics 2013; 172(4): 551-5.

61. Roberts ML, Kino T, Nicolaides NC, Hurt DE, Katsantoni E, Sertedaki A, Komianou F, Kassiou K, Chrousos GP, Charmandari E. A novel point mutation in the DNA-Binding Domain (DBD) of the human glucocorticoid receptor causes Primary Generalized Glucocorticoid Resistance by disrupting the hydrophobic structure of its DBDJournal of Clinical Endocrinology & Metabolism 2013; 98(4): E790-95.

60. Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapyClinical Endocrinology (Oxford) 2013; 78(3): 347-351.

59. Charmandari E, Kino T, Chrousos G. Primary generalized glucocorticoid resistance (Chrousos syndrome) and hypersensitivityEndocrine Development 2013; 24: 67-85.

58. Birbilis M, Moschonis G, Mougios V, Manios Y; Healthy Growth Study’ group (Charmandari E)Obesity in adolescence is associated with perinatal risk factors, parental BMI and sociodemographic characteristicsEuropean Journal of Clinical Nutrition 2013; 67(1): 115-121.

2012

57. Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP. Stress response and child healthScience Signaling 2012; 5(248): mr1.

56. Charmandari EPrimary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress responseScience Signaling 2012; 5(244): pt5.

55. Moschonis G, Chrousos GP, Lionis C, Mougios V, Manios Y; Healthy Growth Study group (Charmandari E)Association of total body and visceral fat mass with iron deficiency in preadolescents: the Healthy Growth StudyBritish Journal of Nutrition 2012; 108(4): 710-719.

54. Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertensionJournal of Clinical Endocrinology & Metabolism 2012; 97(8): E1532-39.

2011

53. Kino T, Charmandari E, Chrousos GP. Glucocorticoid receptor: Implications for rheumatic diseasesClinical and Experimental Rheumatology, 2011; 29(5 Suppl 68): S32-41.

52. Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SSM, Kino T. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in manPLoS One 2011; 6(9): e25612.

51. Charmandari EPrimary generalized glucocorticoid resistance and hypersensitivityHormone Research 2011; 76(3): 145-155.

50. Galata Z, Moschonis G, Makridakis M, Dimitraki P, Nicolaides N, Manios Y, Bartzeliotou A, Chrousos GP, Charmandari EPlasma proteomic analysis in obese and overweight prepubertal childrenEuropean Journal of Clinical Investigation 2011; 41(12): 1275-1283.

2010

49. Charmandari E, Kino T. Chrousos Syndrome: A seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changeEuropean Journal of Clinical Investigation 2010; 40(10): 932-942.

48. Nicolaides N, Galata Z, Chrousos GP, Charmandari EThe glucocorticoid receptor: Evolution, structure and molecular basis of biologic functionSteroids 2010; 75(1): 1-12.

2009

47. Charmandari E, Chrousos GP, Kino T. Identification of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction levelMethods in Molecular Biology 2009; 590:33-60.

46. Chrousos GP, Kino T, Charmandari EEvaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescenceNeuroimmunomodulation 2009; 16(5): 272-283.

2008

45. Kino T, Ichijo T, Zachman K, Chrousos GP, Charmandari EA novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expressionJournal of Clinical Endocrinology & Metabolism 2008; 93(12): 4963-8.

44. Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized Glucocorticoid Resistance: Clinical aspects, molecular mechanisms, and implications of a rare genetic disorderJournal of Clinical Endocrinology & Metabolism 2008; 93(5): 1563-1572.

2007

43. Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, Chrousos GP. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistanceJournal of Clinical Endocrinology & Metabolism 2007; 92(10): 3986 – 3990.

42. Charmandari E, Kino T. Novel causes of generalized glucocorticoid resistanceHormone and Metabolic Research 2007; 39(6): 445-450.

41. Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK. Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthoodJournal of Bone and Mineral Research 2007; 22(1): 110-118.

2006

40. Charmandari E, Chrousos GP. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: Do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Annals of the New York Academy of Sciences 2006; 1083: 37-53.

39. Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, Segars JH. RHO family guanine nucleotide exchange factor BRX couples extracellular signals to the glucocorticoid signaling systemJournal of Biological Chemistry 2006; 281(14): 9118-9126.

38. Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistanceJournal of Clinical Endocrinology & Metabolism 2006; 91(4): 1535-1543.

2005

37. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: The importance of C-terminus of hGR LBD in conferring transactivational activityJournal of Clinical Endocrinology & Metabolism 2005; 90(6): 3696-3705.

36. Charmandari E, Tsigos C, Chrousos GP. Endocrinology of the stress responseAnnual Reviews of Physiology 2005; 67: 259-284.

35. Charmandari E, Chrousos GP, Merke DP. Pituitary adenoma with adrenocorticotropin hypersecretion following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiencyJournal of Pediatric Endocrinology & Metabolism 2005; 18(1): 97-101.

34. Kino T, DeMartino MU, Charmandari E, Outas T, Ichijo T, Pavlakis GN, Chrousos GP. The human immunodeficiency virus type-1 (HIV-1) accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of Forkhead transcription factors by interfering with their binding to 14-3-3 proteins: Potential clinical implications regarding the insulin resistance of HIV-1-infected patientsDiabetes 2005; 54(1): 23-31.

33. Charmandari E, Chrousos GP, Ichijo T, Bhattacharyya N, Vottero A, Souvatzoglou E, Kino T. The human glucocorticoid receptor (GR) β isoform suppresses the transcriptional activity of GRα by interfering with formation of active coactivator complexesMolecular Endocrinology 2005; 19(1): 52-64.

2004

32. Kino T, Liu SH, Charmandari E, Chrousos GP. Clucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: Time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor functionMolecular Medicine 2004; 10(7-12): 80-88.

31. Charmandari E, Brook CGD, Hindmarsh PC. Classic congenital adrenal hyperplasia and pubertyEuropean Journal of Endocrinology 2004; 151 Suppl 3: U77-82.

30. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Chrousos GP, Merke DP. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exerciseJournal of Clinical Endocrinology & Metabolism 2004; 89(8): 3670-3684.

29. Charmandari E, Kino T, Chrousos GP. Familial/Sporadic glucocorticoid resistance: Clinical phenotype and molecular mechanismsAnnals of the New York Academy of Sciences 2004; 1024: 168-181.

28. Charmandari E, Kino T, Chrousos GP. Glucocorticoids and their actionsAnnals of the New York Academy of Sciences 2004; 1024: 1-8.

27. Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW, Chrousos GP. Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stressJournal of Clinical Endocrinology & Metabolism 2004; 89(5): 2228-2236.

26. Charmandari E, Kino T, Vottero A, Souvatzoglou E, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotypeJournal of Clinical Endocrinology & Metabolism 2004; 89(4): 1939-1949.

25. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski J, Chrousos GP, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high intensity exerciseJournal of Clinical Endocrinology & Metabolism 2004; 89(2): 591-597.

24. Chrousos GP, Charmandari E, Kino T. Glucocorticoid action networks: An introduction to systems biologyJournal of Clinical Endocrinology & Metabolism 2004; 89(2): 563-564.

2003

23. Kino T, Charmandari E, Chrousos GP. Basic and clinical implications of glucocorticoid action – Focus on development: Conference ProceedingsHormone and Metabolic Research 2003; 35(10): 628-648.

22. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Sexual dimorphism in the synchrony of joint growth hormone and cortisol secretion in children with classic 21-hydroxylase deficiencyJournal of Pediatric Endocrinology & Metabolism 2003; 16(8): 1119-1130.

21. Kino T, DeMartino M, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromesJournal of Steroid Biochemistry and Molecular Biology 2003; 85(2-5): 457-467.

20. Roche E, Charmandari E, Dattani MT, Hindmarsh PC.Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): A preliminary reportClinical Endocrinology (Oxford) 2003; 58(5): 589-596.

19. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: Hormonal mediators and stress responseHormone Research 2003; 59(4): 161-179.

18. Spoudeas HA, Charmandari E, Brook CGD. Hypothalamo-pituitary-adrenal axis integrity after radiotherapy for childhood posterior fossa tumoursMedical and Pediatric Oncology 2003; 40(4): 224-229.

2002

17. Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension.. Annals of the New York Academy of Sciences 2002; 970: 101-111.

16. Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasiaJournal of Clinical Endocrinology & Metabolism 2002; 87(7): 3197-3200.

15. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiencyJournal of Clinical Endocrinology & Metabolism 2002; 87(7): 3031-3037.

14. Charmandari E, Johnston A, Honour JW, Brook CGD, Hindmarsh PC. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasiaJournal of Pediatric Endocrinology & Metabolism 2002; 15(4): 435-439.

13. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol SecretionJournal of Clinical Endocrinology & Metabolism 2002; 87(5): 2238-2244.

12. Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: Potential clinical implicationsJournal of Clinical Endocrinology & Metabolism 2002; 87(5): 2114-2120.

11. Charmandari E, Brook CGD, Hindmarsh PC. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Archives of Disease in Childhood 2002; 86(4): 266-269.

2001

10. Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CGD. Kinetics and effect of percutaneous administration of dihydrotestosterone in childrenHormone Research 2001; 56(5-6): 177-181.

9. Charmandari E, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: Is current replacement therapy satisfactoryJournal of Clinical Endocrinology & Metabolism 2001; 86(10): 4679-4685.

8. Charmandari E, Pincus SM, Matthews DR, Dennison E, Fall CHD, Hindmarsh PC. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than their male counterpartsJournal of Clinical Endocrinology & Metabolism 2001; 86(7): 3393-3399.

7. Charmandari E, Lichtarowicz-Krynska E, Hindmarsh PC, Aynsley-Green A, Brook CGD. Congenital adrenal hyperplasia: management during critical illnessArchives of Disease in Childhood 2001; 85(1): 26-28.

6. Charmandari E, Hindmarsh PC, Johnston A, Brook CGD. Alterations in cortisol pharmacokinetics at pubertyJournal of Clinical Endocrinology & Metabolism 2001; 86(6): 2701-2708.

5. Charmandari E, Johnston A, Brook CGD, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasiaJournal of Endocrinology 2001; 169(1): 65-70.

4. Charmandari EIs hydrocortisone clearance 50% slower in the evening than in the morning? Journal of Clinical Endocrinology & Metabolism 2001; 86(2): 948-949.

3. Charmandari E, Meadows N, Patel M, Johnston A, Benjamin N. Plasma nitrate concentrations in patients with infective and non-infective enteritisJournal of Pediatric Gastroenterology and Nutrition 2001; 32(4): 423-427.

2000

2. Koziell A, Charmandari E, Hindmarsh PC, Scambler P, Brook CGD. Frasier syndrome and the Wilm’s tumour suppressor GeneClinical Endocrinology (Oxford) 2000; 52(4): 519-524.

1999

1. Charmandari E, Brook CGD. 20 years of experience in idiopathic central diabetes insipidusLancet 1999; 353 (9171): 2212-2213.

Δημοσιεύσεις σε Περιοδικά εκτός SCI

9. Charmandari E. New therapeutic approaches for the management of obesity and diabetes type 2. Clinicae Paediatricae Universitatis Atheniensis 2020 (in press)

8. Charmandari E. Gender Dysphoria: Consensus Guidelines of the Endocrine Society. Clinicae Paediatricae Universitatis Atheniensis 2018; 68(1): 77-83.

7. Charmandari E. National program on the prevention and management of overweight and obesity in childhood and adolescence. Clinicae Paediatricae Universitatis Atheniensis 2013; 60(2): 131-132.

6. Charmandari E. Prevention and management of obesity in childhood and adolescence. Clinicae Paediatricae Universitatis Atheniensis 2013; 60(1): 50-54.

5. Charmandari E. Chrousos Syndrome. Clinicae Paediatricae Universitatis Atheniensis 2011; 58(4): 293-305.

4. Charmandari E. Precocious Puberty. Pediatriki 2010; 73(3): 81-89.

3. Charmandari E. Glucocorticoids. Pediatriki 2009; 72(3): 161-173.

2. Chrousos GP, Kino T, Charmandari E. Generalized glucocorticoid resistance. European Endocrinology 2008; 4(2): 93-99.

1. Charmandari E. Phytoestrogens and child health. Clinicae Paediatricae Universitatis Atheniensis 2008; 55(3): 252-258.

Δημοσιεύσεις σε Βιβλία

38. Lajic S, Karlsson L, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2019; (in press).

37. Nicolaides NC, Charmandari E. Glucocorticoid Resistance. In Genetics of Endocrine Diseases and Syndromes. Peter Igaz & Attila Patócs (eds), Springer Nature, Switzerland, 2019; pages: 85-102.

36. Flueck C, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2018; (in press).

35. Nicolaides NC, Charmandari E, Chrousos GP. Glucocorticoids-Overview. In: Encyclopedia of Endocrine Diseases. Ilpo Huhtaniemi, Luciano Martini & Andre Lacroix (eds), Elsevier, San Diego, CA, USA; 2018 (in press).

34. Nicolaides NC, Charmandari E. Adrenal Insufficiency: Etiology and Diagnosis. In: Encyclopedia of Endocrine Diseases. Ilpo Huhtaniemi, Luciano Martini & Andre Lacroix (eds), Elsevier, San Diego, CA, USA; 2017 (in press).

33. Kassari P, Papaioannou P, Billiris A, Karanikaw H, Eleftheriou S, Thireos E, Manios Y, Chrousos GP, Charmandari E. E-Health: National registry for the prevention and management of of overweight and obesity in childhood and adolescence. In: Publication in honor of emeritus Professor Anagnostopoulos 2017 (in press).

32. Flueck C, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2017; (in press).

31. Nicolaides NC, Lamprokostopoulou A, Sertedaki A, Chrousos GP, Charmandari E. Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis through a Mutated Glucocorticoid Receptor. In: The Hypothalamic Pituitary Adrenal Axis in Health and Disease, Geer E (eds), Springer, New York, NY 10110, USA, 2017; Pages 255-269.

30. Charmandari E, Kyritsi EM, Stratakis C, Sarafoglou K, Chrousos GP. Cushing syndrome in childhood and adolescence. In: Pediatric Endocrinology and Inborn Errors of Metabolism, Sarafoglou K, Hoffmann GF, Roth KS (eds), McGraw Hill, New York, NY 10121, USA; 2017, Part IV, Pages: 561-576.

29. Kyritsi EM, Kourkouti C, Chrousos GP, Charmandari E. Hypercortsolism and Cushing Syndrome. In Biomedical Sciences 2016.

28. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2016; Pages: 97-112.

27. Nicolaides NC, Chrousos GP, Charmandari E. Chrousos Syndrome: From molecular pathogenesis to diagnostic and therapeutic approach. In: Publication in honor of emeritus Professor Emmanuel Kanavakis, Kitsiou S & Mavrou A (editors), Broken Hill Publishers Ltd, Nicosia, Cyprus, 2016; Pages: 553-564.

26. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2015; Pages: 97-114.

25. Nicolaides NC, Charmandari E, Chrousos GP. The hypothalamic-pituitary-adrenal axis in human health and disease. In: Introduction to Translational Cardiovascular Research, Cokkinos D (ed), 2015, Pages: 91-107.

24. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2014; 97-114.

23. Nicolaides NC, Charmandari E, Chrousos GP. Adrenal Steroid Hormone Secretion: Physiologic and Endocrine Aspects. In Encyclopedia of Human Biology, 3rd edition, 2014 (in press).

22. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, JC Carel, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2013; Pages: 97-111.

21. Pervanidou P, Charmandari E, Chrousos GP. Endocrine aspects of childhood obesity. Current Pediatric Reports, Ronald Kleinman (Editor), Springer Science & Business Media, New York, NY, USA; 2013; 109-117.

20. Charmandari E, Kino T, Chrousos GP. Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity. In Endocrine Development, Maghnie M (ed); 2013, Volume 24, Pages: 67–85.

19. Charmandari E, Kino T, Chrousos GP. Primary Generalized Glucocorticoid Resistance and Hypersensitivity. In Endocrine Hypertension, Koch CA, Chrousos GP (eds), Springer, Humana Press, USA, 2013; Pages 69-87.

18. Charmandari E. Delayed Puberty. In: Pediatric and Adolescent Primary Health Care. Chrysanthopoulos C (ed), Rotonda, Thessaloniki, Greece, 2012; Pages: 425-428.

17. Charmandari E. Delayed Puberty. In: Pediatric and Adolescent Primary Health Care. Chrysanthopoulos C (ed), Rotonda, Thessaloniki, Greece, 2012; Pages: 425-428.

16. Charmandari E, Chrousos GP. The Effect of Stress on the Hypothalamic-pituitary-adrenal Axis: An Update. In Neuroendocrine Disorders in Children, Mehul T. Dattani (Editor), McKeith Press, London, UK; 2012 (in press).

15. Charmandari E, Chrousos GP. Primary Generalized Glucocorticoid Resistance or Chrousos syndrome. In Oxford Desk Reference – Endocrinology, Helen Turner, Ashley Grossman and Richard Eastell (eds), Oxford University Press, Oxford, UK; 2012 (in press).

14. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, Ken Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2012; Pages: 99-115.

13. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, JC Carel, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2011; Pages 99-119.

12. Kino T, Charmandari E, Chrousos GP. Disorders of the hypothalamic-pituitary- adrenocortical system. In Handbook of Neuroendocrinology. George Fink, Donald Pfaff and Jon Levine (eds), Elsevier, San Diego, California, USA, 2011, Chapter IV, Pages 639-658.

11. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, JC Carel, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2010; Pages 99-118.

10. Charmandari E, Kino T, Chrousos GP. Glucocorticoids. In Neonatal and Pediatric Pharmacology, 4th Edition. Yaffe SJ and Aranda JV (eds), Lippincott Williams & Wilkins, Philadelphia, PA, USA. 2010; Chapter 51, pages: 760-772.

9. Charmandari E, Chrousos GP, Kino T. Identification of Natural Human Glucocorticoid Receptor (hGR) Mutations or Polymorphisms and their Functional Consequences at the Hormone-Receptor Interaction Level. In Methods in Molecular Biology – Molecular Endocrinology: A Comprehensive Guide to Current Methodologies. Sarge OP and Curry T (eds), Humana Press, USA, 2009; Chapter 3, pages 33-60.

8. Charmandari E. Puberty and Adrenarche. In Reproductive Endocrinology. Mastorakos G (eds) 2008; Chapter 21 (in press).

7. Charmandari E, Kino T, Chrousos GP. Generalized Glucocorticoid Insensitivity: Clinical Phenotype and Molecular Mechanisms. In Overcoming Steroid Insensitivity in Respiratory Disease. Adcock I and Chung F (eds), John Wiley & Sons, Ltd, United Kingdom, 2008; Chapter 5, pages 73-87.

6. Charmandari E, Chrousos GP, Merke DP. Classic Congenital Adrenal Hyperplasia. In Adrenal Glands: Diagnostic Aspects and Surgical Therapy. Linos DA and van Heerden JA (eds) Springer-Verlag, Germany, 2005; Chapter 10, pages 101-114.

5. Kino T, Charmandari E, Chrousos GP. Glucocorticoid action – Basic and clinical implications. Annals of the New York Academy of Sciences 2004; Volume 1024; pages 1-221.

4. Charmandari E, Kino T, Chrousos GP. Glucocorticoids. In Neonatal and Pediatric Pharmacology, 3rd Edition. Yaffe SJ and Aranda JV (eds), Lippincott Williams & Wilkins, Philadelphia, PA, USA. 2004; pages 713-726

3. Charmandari E, Chrousos GP. Glucocorticoids, Overview. In: Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 253-259.

2. Charmandari E, Kino T, Chrousos GP. Glucocorticoid Receptor. In Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 229-234.

1. Charmandari E, Chrousos GP. Adrenal Insufficiency. In Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 75-80.

Δημοσιεύσεις σε Ηλεκτρονικά Βιβλία

18. Nicolaides NC, Kino T, Chrousos GP, Charmandari EAdrenal Insufficiency. Leslie DeGroot (ed). 2017.

17. Nicolaides NC, Kino T, Chrousos GP, Charmandari EPrimary Generalized Glucocorticoid Resistance or Chrousos syndrome. Leslie DeGroot (ed). 2017.

16. Nicolaides NC, Charmandari E. Chrousos syndrome. In Bio: Bio Health. M. Theodorakis (ed).2015.

15. Kyritsi EM, Sertedaki A, Chrousos GP, Charmandari E. Familial or sporadic adrenal hypoplasia syndromes. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2015.​

14.Nicolaides NC, Kino T, Chrousos GP, Charmandari EPrimary Generalized Glucocorticoid Resistance or Chrousos syndrome. Leslie DeGroot (ed). 2014.

13. Nicolaides NC, Chrousos GP, Charmandari EAdrenal Insufficiency. Leslie DeGroot (ed). 2013.

​12. Charmandari E, Kino T, Chrousos GP. Primary Generalized Glucocorticoid Resistance syndrome. In Pediatric Medicine, Endocrinology. Neish SR (ed). 2013.​

11. Karaflou M, Charmandari E, Sertedaki A, Chrousos GP. Familial or sporadic adrenal hypoplasia syndromes. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2011.

10. Nicolaides N, Charmandari E, Chrousos GP. Adrenal insufficiency. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2011.

9. Charmandari E, Kino T, Chrousos GP. Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome). In Pediatric Medicine, Endocrinology. Neish SR (ed). 2011.

8. Kino T, Vottero A, Charmandari E. Primary Generalized Glucocorticoid Resistance or Chrousos syndrome. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2010.

7. Kino T, Charmandari E, Chrousos GP. Glucocorticoid Receptor. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2010

6. Charmandari E, Kino T, Chrousos GP. Molecular mechanisms of glucocorticoid action. In Orpha.net 2004.

5. Charmandari E, Kino T, Chrousos GP. Familial/Sporadic glucocorticoid resistance. In Orpha.net 2004.

4. Charmandari E, Kino T, Chrousos GP. Glucocorticoid resistance syndrome. In Pediatric Medicine, Endocrinology. Neish SR (ed). 2003.

3. Charmandari E, Chrousos GP. Adrenal insufficiency. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 13.

2. Kino T, Charmandari E, Chrousos GP. Glucocorticoid Receptor. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 6.

1. Kino T, Charmandari E, Chrousos GP. Glucocorticoids: synthesis, action, physiology. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 2.